New long-term antimicrobial catheter developed

September 3, 2012

A novel antimicrobial catheter that remains infection-free for up to twelve weeks could dramatically improve the lives of long-term catheter users. The scientists who have developed the new technology are presenting their work at the Society for General Microbiology's Autumn Conference at the University of Warwick.

Researchers at the University of Nottingham have developed a catheter that can kill most urinary bacteria, including most strains of Proteus bacteria – the most common cause of catheter infections. Importantly the antimicrobial catheter retains its activity for between six to twelve weeks, making it suitable for long-term use, unlike existing commercial anti-infection catheters.

are commonly used to manage incontinence in the elderly or individuals who have suffered long-term spinal cord injury. All catheters become infected after a couple of weeks and Proteus bacteria are responsible for up to 40% of these infections. The bacterium sticks to catheter surfaces and breaks down urea, causing the pH of urine to rise. This causes deposits of mineral crystals in the catheter which blocks it, preventing drainage. If unnoticed, catheter blockage can lead to kidney and , which ultimately may result in potentially fatal .

This new antimicrobial catheter has significant advantages over existing solutions, explained Dr Roger Bayston who is leading the development. "Commercial 'anti-infection' catheters are active for only a few days and are not suitable for long-term use. There is an urgent need for an antimicrobial catheter that is suitable for long-term use. Our catheter uses patented technology that does not involve any coatings which extends its . The process involves introducing antimicrobial molecules into the catheter material after manufacture, so that they are evenly distributed throughout it, yet can move through the material to replenish those washed away from the surface."

There are 100 million catheter users worldwide whose lives can be severely disrupted by illness from repeat infections and side-effects from antibiotics. "The catheter technology has proven benefit in other medical settings and has the potential to be the solution to recurrent infections in long-term users, which will improve quality of life of these individuals. In addition, reducing the need to frequently change catheters and treat infections would represent huge financial savings to the NHS," explained Dr Bayston.

Explore further: Antimicrobial catheters could save NHS millions

More information: Dr Bayston's poster presentation "Determining the efficacy of a novel antimicrobial urinary catheter against Proteus mirabilis" will take place on Tuesday 4 September at the Society for General Microbiology's Autumn Conference 2012.

Related Stories

Antimicrobial catheters could save NHS millions

March 27, 2012
A new catheter coating that reduces bacterial attachment to its surface is being developed by scientists who are reporting their work at the Society for General Microbiology's Spring Conference in Dublin this week. The antimicrobial ...

'Smart catheters' for the major problem of catheter-related infections

August 23, 2012
A new "smart catheter" that senses the start of an infection, and automatically releases an anti-bacterial substance, is being developed to combat the problem of catheter-related blood and urinary tract infections, scientists ...

Acne-treating antibiotic cuts catheter infections in dialysis patients

August 19, 2011
Antibiotics can help ward off serious bacterial infections in kidney disease patients who use tubes called catheters for their dialysis treatments. But if antibiotics are used too often, "super bugs" may crop up that are ...

Recommended for you

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.